One of the missions at the CIB Margarita Salas-CSIC consists in making available to society the knowledge and the research results generated in our research center. Thus, we aim to convert our basic research findings into tangible applications, either through the generation and licensing of intellectual property, and/or through the generation of spin-off companies. Currently the CIB Margarita Salas has 8 EBTs considered CSIC spin-offs: Secugen, Protein alternatives, Lifesequencing (now ADM-Lifesequencing), Ankar Pharma, Abvance Biotech, Arrays for Cell Nanodevices (A4CELL), Microbial Biosystems and AItenea Biotech a EBT already constituted (Jun 2020) which will become a CSIC spin-off in the next weeks. In addition, HelpRare is in the process to become a EBT in the coming months and we also had recently the spin-off ProRetina Therapeutics, which closed last year (2007-2019).


     Secugen logo            lifesequencing logo   



Ankar Pharma logo        Abvance     



Proalt Alternatives logo                 A4Cell logo   



                       Microbial B logo   


                               AItenea logo


                                   Help Rare logo